Drugs / EPO
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT02189889 Comparator | Apr 2013 → Jul 2019 | anemia, cardiovascular disorder | University of Texas Southwestern Medical Center | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EPO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02189889 ↗ |
| Route | Subcutaneous | “a subcutaneous injection of EPO 300U/kg” NCT02189889 ↗ |